Metastatic breast cancer: Endocrine therapy landscape reshaped

Metastatic breast cancer: Endocrine therapy landscape reshaped

Endocrine therapy (ET) of hormone receptor (HR)-positive and human epidermal growth factor receptor 2-(HER2)-negative metastatic breast cancer (MBC) historically focused on estrogen deprivation and antagonism. The identification of several intracellular pathways promoting resistance to antiestrogen...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mohamad Adham Salkeni, Samantha June Hall
Formato: article
Lenguaje:EN
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd. 2017
Materias:
breast cancer
endocrine therapy
metastatic
Medicine
R
Acceso en línea:https://doaj.org/article/3269b6d99960484c8d2f4b76e075e6f0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares